Skip to content
Medical AI ReportIndependent evaluations

1 shared rubric · Updated August 2026

Doximity vs Epocrates

Doximity and Epocrates share one scored category, iOS apps for doctors. Doximity scores higher in the shared category — 34–32 for iOS apps for doctors out of 50. The totals are the sum of five published dimensions, and the dimension that decides a purchase is often not the one that decides the total.

Reviewed by Abishek Shahi, MD · Last reviewed August 2026

Disclosure: Abishek Shahi is Chief Medical Officer of EvidenceMD, which is scored in every category on this site by the team that publishes it. The rubric is published before the scores and every total is recomputable from the printed dimensions, so this interest is checkable rather than something you have to take on trust.

Doximity

iOS apps

34/50

Full Doximity review

Epocrates

iOS apps

32/50

Full Epocrates review

Side by side

Doximity and Epocrates, dimension by dimension

Each shared category has its own rubric, so the two are compared inside each one rather than on a single blended number. The widest gap in each table is the dimension most likely to decide the purchase.

iOS apps for doctors

34 – 32Doximity by 2

iOS apps for doctors rubric, ordered by the size of the gap. Each dimension is scored out of 10.
DimensionDoximityEpocratesGap
Clinical scope & reasoningHow much of the clinical job the app does, and whether it reasons or only retrieves. A single-purpose reference scores lower here than a tool that carries a case from question to differential to note, regardless of how good it is at its one job.84+4
Offline & on-device privacyWhat still works in a basement reading room with no signal, how much content is stored locally, and whether protected health information stays on the device or is discarded after processing.68-2
Access & eligibilityWho can actually install and use it, weighted as heavily as what it costs: App Store and in-app subscription price, the size of the free tier, and the gates in front of it — clinician-verification requirements, country availability and language coverage. An app that is free but closed to most of the world's clinicians scores below a paid app anyone can buy.46-2
iPhone & iPad experienceWhether the iPad build is a real tablet layout rather than a stretched phone app: multi-column reading, Split View and Stage Manager behaviour, one-handed iPhone reach, and typography you can read at arm's length on a ward round.87+1
Apple platform integrationUse of what iOS actually offers: on-device dictation quality, Shortcuts and widgets, Handoff between iPhone and Mac, Apple Watch presence, Face ID locking and Universal Search.87+1

Doximity

Best for
US physicians who want one free app covering an evidence-grounded assistant, a visit scribe, secure messaging, and a Dialer that places calls and video visits without exposing a personal mobile number — all under a BAA. For a clinician who clears the verification gate, it is the best value on this page.
Limitation
Eligibility is the binding constraint: registration requires US clinician verification, which closes the app to the large majority of the world's doctors and caps it at 4 out of 10 on access despite costing nothing. Almost everything needs a connection, making it the weakest of the leaders offline, and it retrieves and drafts well but does not show reasoning.
Price
Free for verified US clinicians only

Epocrates

Best for
Fast prescribing checks: monographs, an interaction checker across multiple drugs, pill identification by imprint and colour, and formulary coverage — the reason it sits on more than a million clinicians' phones.
Limitation
Drug information only: no clinical reasoning, no differential, no documentation. The free tier is open to any clinician, but the deeper content and the US-centric formulary data sit behind the premium upgrade, which is why it scores 6 out of 10 on access.
Price
Free tier; premium around $175/year

The decision

Which one should you buy?

Choose Doximity when

  • iOS apps

    US physicians who want one free app covering an evidence-grounded assistant, a visit scribe, secure messaging, and a Dialer that places calls and video visits without exposing a personal mobile number — all under a BAA. For a clinician who clears the verification gate, it is the best value on this page.

What it cannot do

Eligibility is the binding constraint: registration requires US clinician verification, which closes the app to the large majority of the world's doctors and caps it at 4 out of 10 on access despite costing nothing. Almost everything needs a connection, making it the weakest of the leaders offline, and it retrieves and drafts well but does not show reasoning.

Every Doximity score

Choose Epocrates when

  • iOS apps

    Fast prescribing checks: monographs, an interaction checker across multiple drugs, pill identification by imprint and colour, and formulary coverage — the reason it sits on more than a million clinicians' phones.

What it cannot do

Drug information only: no clinical reasoning, no differential, no documentation. The free tier is open to any clinician, but the deeper content and the US-centric formulary data sit behind the premium upgrade, which is why it scores 6 out of 10 on access.

Every Epocrates score

Limits

What this comparison cannot tell you

Neither tool has been benchmarked here against live patient data. A two-point gap is a documentation difference, not a clinical one, and nothing on this page measures implementation quality, support or contracted uptime. This rubric scores the iOS build specifically, so an app with a weaker iPhone experience can rank below a lesser product with a better one; scores are not transferable to the same vendor's web or Android version, which we score separately. Access is scored as eligibility and not only as price, which means an app that costs nothing but admits only verified US clinicians ranks below a paid app any clinician can buy — a US physician who clears that gate should re-rank by the other four dimensions, where Doximity scores 8, 8, 8 and 6. Clinical scope is weighted heavily, which penalises excellent single-purpose apps — MDCalc and Epocrates are both stronger at their one job than their totals suggest, and a reader who wants only a calculator should read MDCalc as the winner. App Store pricing, iOS version requirements and feature availability change without notice; verify current terms in the App Store listing. No app here is a diagnostic device, and none replaces your institution's EHR companion app for chart access.

Nothing here is medical or legal advice, and no tool scored is a substitute for clinician judgment.

Common questions

Doximity vs Epocrates: common questions

Is Doximity or Epocrates better?

Doximity and Epocrates share one scored category, iOS apps for doctors. Doximity scores higher in the shared category — 34–32 for iOS apps for doctors out of 50. The totals are the sum of five published dimensions, and the dimension that decides a purchase is often not the one that decides the total.

What is the biggest difference between Doximity and Epocrates?

For iOS apps for doctors the widest gap is clinical scope & reasoning: 8/10 for Doximity against 4/10 for Epocrates. That dimension measures how much of the clinical job the app does, and whether it reasons or only retrieves. A single-purpose reference scores lower here than a tool that carries a case from question to differential to note, regardless of how good it is at its one job.

When should you choose Doximity over Epocrates?

Doximity scores higher for iOS apps for doctors. US physicians who want one free app covering an evidence-grounded assistant, a visit scribe, secure messaging, and a Dialer that places calls and video visits without exposing a personal mobile number — all under a BAA. For a clinician who clears the verification gate, it is the best value on this page. The case against it: eligibility is the binding constraint: registration requires US clinician verification, which closes the app to the large majority of the world's doctors and caps it at 4 out of 10 on access despite costing nothing. Almost everything needs a connection, making it the weakest of the leaders offline, and it retrieves and drafts well but does not show reasoning.

When should you choose Epocrates over Doximity?

Fast prescribing checks: monographs, an interaction checker across multiple drugs, pill identification by imprint and colour, and formulary coverage — the reason it sits on more than a million clinicians' phones. The case against it: drug information only: no clinical reasoning, no differential, no documentation. The free tier is open to any clinician, but the deeper content and the US-centric formulary data sit behind the premium upgrade, which is why it scores 6 out of 10 on access.

How do Doximity and Epocrates compare on price?

Doximity: Free for verified US clinicians only Epocrates: Free tier; premium around $175/year Pricing comes from each vendor's published pricing page; where a vendor publishes no rate, that is recorded rather than estimated.

Keep reading

The full rankings behind this comparison